We are delighted to announce that Dr. Aubrey de Grey has accepted our offer to join the LEAF scientific advisory board, and he joins the other luminaries whose expertise we already benefit from.
The majority of you already know about Dr. Aubrey de Grey and his work at the SENS Research Foundation, but for those who are not familiar with him, here is a short introduction.
Decades on, his work remains an irresistible trove of ideas for film-makers to plunder. Philip K Dick’s Electric Dreams, which begins on Sunday (Channel 4, 9pm), is an ambitious series of 10 one-hour films based on his stories, with different casts and creative teams.
An ambitious series of 10 one-hour films based on the stories of the sci-fi writer.
At well over $150,000 per appliance, the Volta GPU based DGX appliances from Nvidia, which take aim at deep learning with framework integration and 8 Volta-accelerated nodes linked with NVlink, is set to appeal to the most bleeding edge of machine learning shops.
Nvidia has built its own clusters by stringing several of these together, just as researchers at Tokyo Tech have done with the Pascal generation systems. But one of the first commercial customers for the Volta based boxes is the Center for Clinical Data Science, which is part of the first wave of hospitals set to use deep learning for MR and CT image analysis.
The center, which is based in Cambridge, Massachusetts, has secured a whopping four DGX-1 Volta appliances, which sport the latest GPUs with eight per node with the NVlink interconnect. The Next Platform talked with Neil Tenenholtz, senior data scientist at the center, about where deep learning will yield results for hospitals and medical research and about their early experiences with the four machines.
Continue reading “Hospital Captures First Commercial Volta GPU Based DGX-1 Systems” »
Doing well on such a challenge would appear to require significant advances in AI technology, making it a potentially powerful way to advance the field. In this video, Carissa Schoenick discusses “Moving Beyond the Turing Test with the Allen AI Science Challenge,” in the September 2017 CACM.
At the Disrupt SF 2017 Hackathon, a massive swath of the 102 companies that took the stage on Sunday presented hacks with disaster relief in mind. From ResQme to ResQMi to RescueMe, if you can think of a phrase with the word “rescue” in it, it probably showed up on stage among the roughly 30 emergency and disaster related hacks.
Most of the disaster-related apps that presented today mentioned the recent events of Hurricane Harvey and Hurricane Irma in their pitches, observing that tech should be able to pair victims, resources and rescue workers far better than existing services. Many of the rescue-oriented apps that took the stage acknowledged that mobile data services usually go down during these events and the vast majority of them offered an SMS-based version of their hack.
Continue reading “Disaster relief hacks dominate the stage at the Disrupt SF 2017 Hackathon” »
AgeX Therapeutics: A Discussion with Dr. Aubrey de Grey, V.P. New Technology Discovery and Dr. Michael West. Co-CEO of BioTime & CEO of AgeX Therapeutics.
Continue reading “Aubrey de Grey on The State of Anti-Aging & His New Job At AgeX Therapeutics” »
The new self-propelled, cancer-seeking bacteriobot swims right into the tumor and zaps it with a deadly payload of cancer drugs.
The recently perfected #bacteriobot holds ‘a lot of promise’ in treating #cancer says a physician. Cancer patients at a hospital in Montreal may be the first to be treated with these #nanorobots built out of bacteria.
Summary: The recently perfected bacteriobot holds ‘a lot of promise’ in treating cancer says a physician. Cancer patients at a hospital in Montreal may be the first to be treated with nanorobots built out of bacteria. The new self-propelled, cancer-seeking bacteriobot swims right into the tumor and zaps it with a deadly payload of cancer drugs. [Cover image: Getty Images/iStock.]
Continue reading “Bacteriobot Holds ‘A Lot Of Promise’ To Treat Cancer, Says Doctor” »
Current international shipping law states that ocean-going vessels must be properly crewed, so fully autonomous, unmanned ships aren’t allowed in international waters. As such, the Yara Birkeland will have to operate close to the Norweigan coast at all times, carrying out regular short journeys between three ports in the south of the country.
But change is afoot in the maritime sector, and earlier this year the UN’s International Maritime Organisation (IMO) began discussions that could allow unmanned ships to operate across oceans. This raises the prospect of crewless “ghost” ships crisscrossing the ocean, with the potential for cheaper shipping with fewer accidents.
Several Japanese shipping firms, for example, are reportedly investing hundreds of millions of dollars in the technology. And British firm Rolls-Royce demonstrated the world’s first remote-controlled unmanned commercial ship earlier this year.
Continue reading “Unmanned ‘ghost’ ships are coming to our oceans” »
https://www.youtube.com/watch?v=Yx3qbJ2E-hY
Full Interview ► https://goo.gl/PvUjjU
Michael B. Fossel, M.D., Ph.D. (born 1950, Greenwich, Connecticut) was a professor of clinical medicine at Michigan State University and is the author of several books on aging, who is best known for his views on telomerase therapy as a possible treatment for cellular senescence. Fossel has appeared on many major news programs to discuss aging and has appeared regularly on National Public Radio (NPR). He is also a respected lecturer, author, and the founder and former editor-in-chief of the Journal of Anti-Aging Medicine (now known as Rejuvenation Research).
Shai Ben-David, Professor at the University of Waterloo, gave Machine Learning Course composed of 23 Lectures (CS 485/685) at the University of Waterloo on Jan 14, 2015…
Machine learning is the science of getting computers to act without being explicitly programmed. In the past decade, machine learning has given us self-driving cars, practical speech recognition, effective web search, and a vastly improved understanding of the human genome. Machine learning is so pervasive today that you probably use it dozens of times a day without knowing it. Many researchers also think it is the best way to make progress towards human-level AI.
Continue reading “Artificial Intelligence and Magnificent Brain” »
